Releases
OPNT
20.65
0.00%
0.00
  • All
  • Financials
  • Insiders
More
Webull provides the latest Opiant Pharmaceuticals Inc (OPNT) stock and general news. This information may help you make smarter investment decisions.
About OPNT
Opiant Pharmaceuticals, Inc., is a specialty pharmaceutical company developing medicines for addictions and drug overdose. The Company has developed NARCAN (naloxone hydrochloride) Nasal Spray, a treatment to reverse opioid overdose. Its lead development product include OPNT003. The Company’s pipeline includes medicines in development for Opioid Overdose Reversal (OOR), Alcohol Use Disorder (AUD), Opioid Use Disorder (OUD), and Acute Cannabinoid Overdose (ACO). The Company also is focused on other treatment opportunities within the addiction and drug overdose field.